Genomic variants within chromosome 14q32.32 regulate bone mass through MARK3 signaling in osteoblasts

J Clin Invest. 2021 Apr 1;131(7):e142580. doi: 10.1172/JCI142580.

Abstract

Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass.

Keywords: Bioinformatics; Bone Biology; Bone development; Osteoclast/osteoblast biology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Bone Density / genetics*
  • Bone and Bones / cytology
  • Bone and Bones / metabolism*
  • Chromosomes, Mammalian* / genetics
  • Chromosomes, Mammalian* / metabolism
  • Genetic Variation*
  • Mice
  • Mice, Knockout
  • Organ Size / genetics
  • Osteoblasts / cytology
  • Osteoblasts / metabolism*
  • Protein Serine-Threonine Kinases* / genetics
  • Protein Serine-Threonine Kinases* / metabolism
  • Signal Transduction / genetics*

Substances

  • Mark3 protein, mouse
  • Protein Serine-Threonine Kinases